Roivant Sciences CFO Richard Pulik sells 125,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Roivant Sciences Ltd. CFO Richard Pulik exercised options for 125,000 common shares on November 10 and 127,365 shares on November 11, each at $3.85 per share. He sold 125,000 shares at $41.20 per share on November 10. On November 11, he sold 45,195 shares at a weighted average price of $41.47, 82,170 at $42.03 and 47,635 at $41.89. The option award was fully vested.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F5 | 127,365 | $0.00 | $0.00 |
| Exercise | Common Shares | 127,365 | $3.85 | $490K |
| Sale | Common Shares F2 | 45,195 | $41.47 | $1.87M |
| Sale | Common Shares F3 | 82,170 | $42.03 | $3.45M |
| Sale | Common Shares F4 | 47,635 | $41.89 | $2.00M |
| Exercise | Stock Option (Right to Buy) F5 | 125,000 | $0.00 | $0.00 |
| Exercise | Common Shares | 125,000 | $3.85 | $481K |
| Sale | Common Shares F1 | 125,000 | $41.20 | $5.15M |
Footnotes (5)
- F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.16 to $41.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.88 to $41.83, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.94 to $42.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.79 to $42.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F5. Reflects an award of stock options to purchase Common Shares that is fully vested.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
weighted average price financial
fully vested financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ROIV options did Richard Pulik exercise, and at what price?
AI-generated analysis. How Rhea-AI works. Not financial advice.